Another strong effort- saves me form having to google failed psoriasis trials looking for lack of correlation of murine to human results. I actually did start this task, but it is annoying, and slow, and I am lazy.
In the long run does P even matter? It would be awfully nice to see the company take off sooner rather than later, and a deal for P would be so helpful for getting cash for other projects- like money for Mayo and pancreatic CA trial, just one example.
The stock will be driven by B in its various guises and by K, but so much of this benefit is a long way off that one is tempted to get hopes raised by P prospects. Let's say P fails- drop to a dollar likely, my guess. And then how long till it gets pulled back up? B-OM data a long way off- a year, maybe? None of the other drivers will have results for a couple of years. Most important are the phase 2's for K and that will be 2 years from now for results?
So if P fails there is a very long period where CTIX will have no catalysts, and it will be a real test. Something like a darkness before the dawn, whereas dawn could start early with Prurisol success. How daylight savings time impacts the earliness of dawn is not clear to me, in this instance.
A very long night ahead of us, or an early dawn, if one's mind runs toward light and darkness as metaphors.
I suppose considering the recent Boston weather I should have just stuck with rain and sun...